documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
31 rows where docket_id = "FDA-1975-N-0336" and posted_year = 2011 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, last_modified, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1975-N-0336-0031 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Hearing with Supporting Information Regarding Proposed Withdrawal of Approved Applications for Anticholinergic and Barbiturate Combination Drug Products - Supplemental Information (Vol. 141-B) | Other | Request for Hearing | 2011-09-13T04:00:00Z | 2011 | 9 | 2011-09-13T04:00:00Z | 2017-12-05T21:44:07Z | 0 | 0 | 0900006480ee57db | ||
| FDA-1975-N-0336-0027 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Premo Pharmaceutical Labs, Inc., - [Sheppard Mulln Richter & Hampton LLP] DESI 10837 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:20Z | 1 | 0 | 0900006480f08fee | ||
| FDA-1975-N-0336-0015 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Poythress Laboratories, Inc., DESI 597 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:38:48Z | 0 | 0 | 0900006480f08da7 | ||
| FDA-1975-N-0336-0030 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Cord Labs, Inc., - [Arent Fox LLP] DESI 10837 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:49:09Z | 0 | 0 | 0900006480f08ff6 | ||
| FDA-1975-N-0336-0024 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Beecham Laboratories, DESI 597 - [ Kleinfeld, Kaplan & Becker LLP] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:46:03Z | 0 | 0 | 0900006480f08fb3 | ||
| FDA-1975-N-0336-0026 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Premo Pharmaceutical. - [Teva Pharmaceuticals] DESI 10837 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-12T05:03:05Z | 1 | 0 | 0900006480f08fb7 | ||
| FDA-1975-N-0336-0017 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Reid-Provident Laboratories, Inc.'s., DESI 597 [ Abbott Laboratories] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:37Z | 1 | 0 | 0900006480f08ede | ||
| FDA-1975-N-0336-0019 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Sandoz, Inc's - [ Kleinfeld, Kaplan & Becker LLP] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:31Z | 1 | 0 | 0900006480f08ee2 | ||
| FDA-1975-N-0336-0023 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to B.F. Ascher & Co., Inc., DESI 597 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-12T05:03:05Z | 1 | 0 | 0900006480f08f95 | ||
| FDA-1975-N-0336-0025 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Richlyn Laboratories, Inc.., - [Impax Laboratories, Inc.] DESI 597 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-12T05:03:05Z | 1 | 0 | 0900006480f08fb5 | ||
| FDA-1975-N-0336-0021 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to West-Ward Pharmaceutical Corp., DESI 597 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2013-01-08T03:27:35Z | 0 | 0 | 0900006480f08f91 | ||
| FDA-1975-N-0336-0014 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to National Pharmaceuticals Manufacturing Co.,, DESI 597 - [ Actavis US] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:30Z | 1 | 0 | 0900006480f08da5 | ||
| FDA-1975-N-0336-0016 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Purepac Pharmaceutical's - [ Actavis ] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:39:08Z | 0 | 0 | 0900006480f08edc | ||
| FDA-1975-N-0336-0022 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to William Rorer, Inc., DESI 597 [ Sanofi-aventis U,S.] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-12T05:03:04Z | 1 | 0 | 0900006480f08f93 | ||
| FDA-1975-N-0336-0020 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Stuart Pharmaceuticals, DESI 597 - [ AstraZeneca Pharmaceuticals LP] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:42:14Z | 0 | 0 | 0900006480f08f8d | ||
| FDA-1975-N-0336-0028 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Roche pharmaceutical, - [Genentech, Inc.] - DESI 10837 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2011-08-30T19:48:23Z | 0 | 0 | 0900006480f08ff0 | ||
| FDA-1975-N-0336-0029 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Roche Laboratories, - [Valeant Pharmaceuticals International, Inc] - DESI 10837 - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:38Z | 1 | 0 | 0900006480f08ff4 | ||
| FDA-1975-N-0336-0018 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Sandoz, Inc's - [ Kleinfeld, Kaplan & Becker LLP] - Letter | Other | Letter(s) | 2011-08-30T04:00:00Z | 2011 | 8 | 2011-08-30T04:00:00Z | 2024-11-07T22:36:30Z | 1 | 0 | 0900006480f08ee0 | ||
| FDA-1975-N-0336-0012 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDERLletter to Lemmon Co., DESI 597 - [ Teva Pharmaceuticals Co.] - Letter | Other | Letter(s) | 2011-08-29T04:00:00Z | 2011 | 8 | 2011-08-29T04:00:00Z | 2024-11-12T05:02:18Z | 1 | 0 | 0900006480f076b7 | ||
| FDA-1975-N-0336-0006 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Carter-Wallace, Inc., DESI 597 - [ Kleinfeld, Kaplan & Becker LLP] - Letter | Other | Letter(s) | 2011-08-29T04:00:00Z | 2011 | 8 | 2011-08-29T04:00:00Z | 2011-08-30T19:33:06Z | 0 | 0 | 0900006480f07671 | ||
| FDA-1975-N-0336-0007 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Ferdale Pharma Group, Inc - Letter | Other | Letter(s) | 2011-08-29T04:00:00Z | 2011 | 8 | 2011-08-29T04:00:00Z | 2011-08-30T19:33:22Z | 0 | 0 | 0900006480f07678 | ||
| FDA-1975-N-0336-0013 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER letter to McNeil Pharmaceuticals., DESI 597 - [ Ortho-McNeil-Janssen Pharmaceuticals Inc.] - Letter | Other | Letter(s) | 2011-08-29T04:00:00Z | 2011 | 8 | 2011-08-29T04:00:00Z | 2011-08-30T19:37:33Z | 0 | 0 | 0900006480f076ba | ||
| FDA-1975-N-0336-0009 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER letter to Halsey Drug Co. - [ Acura Pharmaceuticals Co.] - Letter | Other | Letter(s) | 2011-08-29T04:00:00Z | 2011 | 8 | 2011-08-29T04:00:00Z | 2024-11-07T22:36:38Z | 1 | 0 | 0900006480f076a0 | ||
| FDA-1975-N-0336-0011 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Lemmon Co., DESI 597 - [ Teva Pharmaceuticals Co.] - Letter | Other | Letter(s) | 2011-08-29T04:00:00Z | 2011 | 8 | 2011-08-29T04:00:00Z | 2024-11-07T22:36:30Z | 1 | 0 | 0900006480f076b2 | ||
| FDA-1975-N-0336-0008 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER Letter to Halsey Drug Co., DESI 597 - [ Acura Pharmaceuticals Co.] - Letter | Other | Letter(s) | 2011-08-29T04:00:00Z | 2011 | 8 | 2011-08-29T04:00:00Z | 2011-08-30T19:33:37Z | 0 | 0 | 0900006480f0767c | ||
| FDA-1975-N-0336-0010 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/CDER letter to Kremers-Urban Co. DESI 597 - [ Kleinfeld, Kaplan & Becker LLP] - Letter | Other | Letter(s) | 2011-08-29T04:00:00Z | 2011 | 8 | 2011-08-29T04:00:00Z | 2024-11-07T22:36:30Z | 1 | 0 | 0900006480f076a2 | ||
| FDA-1975-N-0336-0005 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from FDA CDER to Kleindeld, Kaplan & Becker LLP | Other | Letter(s) | 2011-08-25T04:00:00Z | 2011 | 8 | 2011-08-25T04:00:00Z | 2017-11-13T18:35:08Z | 0 | 0 | 0900006480eeb8ed | ||
| FDA-1975-N-0336-0004 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Request for Hearing with Supporting Information Regarding Proposed Withdrawal of Approved Applications for Anticholinergic and Barbiturate Combination Drug Products (Buchanan Ingersoll & Rooney PC) (Vol 141-A) | Other | Request for Hearing | 2011-08-11T04:00:00Z | 2011 | 8 | 2011-08-11T04:00:00Z | 2017-12-05T21:41:21Z | 0 | 0 | 0900006480ec1a8d | ||
| FDA-1975-N-0336-0003 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | FDA/OC to PMB Pharmaceuticals, Inc.(Buchanan Ingersoll & Rooney, PC) - Letter | Other | Letter(s) | 2011-08-09T04:00:00Z | 2011 | 8 | 2011-08-09T04:00:00Z | 2011-08-09T19:57:46Z | 0 | 0 | 0900006480edc698 | ||
| FDA-1975-N-0336-0001 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from West-Ward Pharmaceutical Corporation and PBM Pharmaceutical, Inc. to FDA/CDER | Other | Letter(s) | 2011-07-14T04:00:00Z | 2011 | 7 | 2011-07-14T04:00:00Z | 2017-12-06T15:37:11Z | 0 | 0 | 0900006480ebd5c8 | ||
| FDA-1975-N-0336-0002 | FDA | Drugs Containing Anticholinergic/Antispasmodic Combination FDA-1975-N-0336 | Letter from PBM Pharmaceutical, Inc. (Buchanan Ingersoll and Rooney, PC) to FDA | Other | Letter(s) | 2011-07-14T04:00:00Z | 2011 | 7 | 2011-07-14T04:00:00Z | 2017-12-06T15:54:22Z | 0 | 0 | 0900006480ebd5ca |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;